Latest Cleo Diagnostics (ASX:COV) News
Page 1
Page 1 of 4
Healthcare Wrap - Week 46 (9 Nov -> 13 Nov) 2026
14 Nov 2026
Cleo installs US lab infrastructure for 1,470-sample ovarian cancer validation
12 Nov 2026
Market Wrap - Week 43 (19 Oct -> 23 Oct) 2026
24 Oct 2026
Healthcare Wrap - Week 43 (19 Oct -> 23 Oct) 2026
24 Oct 2026
Cleo ovarian cancer test clears first screening hurdle with strong early-stage results
21 Oct 2026
Cleo Starts Formal Testing of Ovarian Cancer Assay Ahead of FDA Filing
13 Oct 2026
Cleo Targets Ovarian Cancer Screening With New Multi-Biomarker Test
24 Sept 2026
Healthcare Wrap - Week 37 (7 Sept -> 11 Sept) 2026
12 Sept 2026
Cleo Names Asuragen for 1,470-Sample Ovarian Cancer Test Validation
10 Sept 2026
Healthcare Wrap - Week 36 (31 Aug -> 4 Sept) 2026
5 Sept 2026
Cleo Diagnostics Begins Analytical Validation of Ovarian Cancer Test Kits
3 Sept 2026
Healthcare Wrap - Week 31 (27 July -> 31 July) 2026
1 Aug 2026